Viridian Therapeutics Inc (VRDN)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
SERVICES-MEDICAL LABORATORIES
CEO:
Jonathan Violin
Employees:
77
6200 LOOKOUT ROAD, BOULDER, CO 80301
720.643.5200

Viridian Therapeutics, Inc. formerly: MIRAGEN THERAPEUTICS, INC. operates as a biotechnology company. The Company specializes in developing multiple product candidates to treat patients who suffer from thyroid eye disease (TED), a debilitating orphan disease, and has early-stage programs focused on other targets and indications.

Data as of 2021-10-17 09:57:26 -0400
Market Cap163.653 Million Shares Outstanding9.587 Million Avg 30-day Volume573.924 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-3.19 Enterprise Value
Total Cash Current Debt Gross Profit
BETA-2.12163 52-week High/Low25.67 / 7.08 Next Earnings Date2021-11-09 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from VRDN instead.

View recent insider trading info

Funds Holding VRDN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VRDN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

1.1 Million total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MEISNER LARA GENERAL COUNSEL AND SECRETARY

  • Officer
0 2021-10-01 1

FRAZIER LIFE SCIENCES PUBLIC FUND, L.P.

FHMLSP, L.P.

FHMLSP, L.L.C.

  • 10% Owner
1,505,200 2021-09-23 2

FAIRMOUNT FUNDS MANAGEMENT LLC

FAIRMOUNT HEALTHCARE FUND GP LLC

FAIRMOUNT HEALTHCARE FUND II GP LLC

FAIRMOUNT HEALTHCARE FUND L.P.

FAIRMOUNT HEALTHCARE FUND II L.P.

  • Director
  • 10% Owner
  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
1,077,283 2021-09-21 1

HUMER KRISTIAN CFO AND CBO

  • Officer
0 2021-07-26 3

MOSES JENNIFER K.

  • Director
0 2021-07-14 2

MORRIS ARLENE

  • Director
12,500 2021-06-03 2

HARWIN PETER EVAN

  • Director
12,500 2021-06-03 4

KISELAK TOMAS

  • Director
12,500 2021-06-03 4

TURNER JOSEPH L

  • Director
0 2021-02-04 1

HATFIELD JEFFREY S.

  • Director
0 2021-02-04 1

KATZ BARRETT CHIEF MEDICAL OFFICER

  • Officer
0 2021-01-20 2

LEVERONE JASON A. CHIEF FINANCIAL OFFICER

  • Officer
0 2021-01-18 1

VIOLIN JONATHAN CEO AND PRESIDENT

  • Officer
  • Director
0 2021-01-18 3

ESCOLAR DIANA FORMER CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2021-01-15 1

RAUCH LEE M.

  • SEE REMARKS
No longer subject to file 2021-01-15 1

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
410,686 2020-12-07 1

POINT72 ASSET MANAGEMENT, L.P.

POINT72 CAPITAL ADVISORS, INC.

COHEN STEVEN A/SAC CAPITAL MGMT LP

  • 10% Owner
426,162 2020-11-10 1

LOGOS GLOBAL MASTER FUND LP

  • 10% Owner
6,900,000 2020-11-09 2

MARSHALL WILLIAM STUART

  • SEE REMARKS
No longer subject to file 2020-10-15 0

KOCH KEVIN

  • Director
0 2020-05-21 0

BOWDEN CHRISTOPHER

  • Director
0 2020-05-21 0

HUGHES THOMAS E.

  • Director
0 2020-05-21 0

RUBIN PAUL D EVP, RESEARCH & DEVELOPMENT

  • Officer
0 2019-02-06 0

LEVY ADAM SCOTT CHIEF BUSINESS OFFICER

  • Officer
0 2019-02-06 0

BOOTH BRUCE

  • Director
0 2018-06-27 0

LEFKOFF KYLE

  • Director
0 2017-06-28 0

CREECY JOHN W

  • Director
0 2017-06-28 0

LEBOW BENNETT S

  • Director
  • 10% Owner
No longer subject to file 2017-02-13 0

ATLAS VENTURE FUND VII L P

  • 10% Owner
3,142,580 2017-02-13 0

REMEDITEX VENTURES LLC

  • 10% Owner
2,706,563 2017-02-13 0

GONYER DAVID A

  • Director
1,899 2017-02-08 0

SMITH ROBIN L

  • Director
1,900 2017-02-03 0

SEYMOUR TAMARA A CFO, SECRETARY, TREASURER

  • Officer
106,447 2016-10-31 0

RICCITELLI SAMUEL D PRESIDENT & CEO

  • Officer
  • Director
571,370 2016-10-31 0

SCHULING DOUGLAS A

  • Director
0 2016-06-15 0

LEBOW BENNETT S

LEBOW ALPHA, LLLP

  • Director
  • 10% Owner
2,232,629 2014-06-17 0

JOHNSON ROBERT BRIAN CFO AND CAO

  • Officer
0 2014-06-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

FRAZIER LIFE SCIENCES PUBLIC FUND, L.P. - > 10% Owner

FHMLSP, L.P. - > 10% Owner

FHMLSP, L.L.C. - > 10% Owner

2021-09-28 19:46:45 -0400 2021-09-23 P 200,000 $11.00 a 1,505,200 direct -3.2353 2.0588 3.0588 5 -3.2353 2

FAIRMOUNT FUNDS MANAGEMENT LLC - Director - > 10% Owner fairmount healthcare fund ii lp

FAIRMOUNT HEALTHCARE FUND GP LLC - Director SEE REMARKS fairmount healthcare fund ii lp

FAIRMOUNT HEALTHCARE FUND II GP LLC - Director SEE REMARKS fairmount healthcare fund ii lp

FAIRMOUNT HEALTHCARE FUND L.P. - Director SEE REMARKS fairmount healthcare fund ii lp

FAIRMOUNT HEALTHCARE FUND II L.P. - Director SEE REMARKS fairmount healthcare fund ii lp

2021-09-23 09:30:09 -0400 2021-09-21 P 909,000 $11.00 a 938,233 indirect 10.9104 14.3155 21.6122 4 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 22:15:03 UTC -7.3525 7.4225 75000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 21:45:03 UTC -7.3525 7.4225 75000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 21:15:03 UTC -7.3525 7.4225 75000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 20:45:03 UTC -7.3525 7.4225 75000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 20:15:03 UTC -7.3525 7.4225 75000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 19:45:03 UTC -7.3525 7.4225 75000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 19:15:03 UTC -7.3525 7.4225 75000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 18:45:03 UTC -7.3525 7.4225 75000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 18:15:03 UTC -7.3525 7.4225 75000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 17:45:03 UTC -7.3525 7.4225 75000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 17:15:03 UTC -7.3525 7.4225 75000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 16:45:03 UTC -7.3525 7.4225 75000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 16:15:04 UTC -7.3525 7.4225 75000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 15:45:03 UTC -7.3525 7.4225 45000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 15:15:03 UTC -7.3525 7.4225 45000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 14:45:03 UTC -6.0289 6.0989 45000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 14:15:03 UTC -6.0289 6.0989 45000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 13:45:03 UTC -6.0289 6.0989 45000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 13:15:03 UTC -6.0289 6.0989 45000
VIRIDIAN THERAPEUTICS INC VRDN 2021-10-22 12:45:03 UTC -6.0289 6.0989 45000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments